The study for usefullness of zinc administration in patients with chronic liver diseases

The study for usefullness of zinc administration in patients with chronic liver diseases - ZINC THINK study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032023

Enrollment

200

Registered

2018-05-01

Start date

2018-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic liver diseases

Interventions

administration of zinc preparation(zinc acetate, zinc sulfate)(one year) 50-150mg zinc equivalent without taking zinc preparation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 patients diagnosed as chronic liver diseases 2 patients are not taking zinc preparation

Exclusion criteria

Exclusion criteria: 1 patients who are considered to be inappropriate for this study by atttending physician

Design outcomes

Primary

Measure	Time frame
cumulative survival rate, HCC incidence rate, event incidence rate(varix rupture,refractory pleural effusion/ascites, and cancer development), liver function	—

Countries

Japan,Asia(except Japan)

Contacts

Public ContactAtsushi Hosui

Osaka-Rosai Hospital Department of Gastroenterology and Hepatology

hosui@osakah.johas.go.jp072-252-3561

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026